Sulfonamide-Based Azaheterocyclic Schiff Base Derivatives as Potential Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxicity, and Enzyme Inhibitory Kinetics
- PMID: 32149140
- PMCID: PMC7054763
- DOI: 10.1155/2020/8104107
Sulfonamide-Based Azaheterocyclic Schiff Base Derivatives as Potential Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxicity, and Enzyme Inhibitory Kinetics
Abstract
A series of sulfonamide-bearing azaheterocyclic Schiff base derivatives 3(a-j) were synthesized as carbonic anhydrase inhibitors. The substituted benzene sulfonyl chlorides 1(a-d) were reacted with N2H4 to get aromatic sulfonyl hydrazides 2(a-d). The intermediate hydrazides 2(a-d) were treated with substituted aldehydes to afford azaheterocyclic sulfonamide Schiff bases 3(a-j). The spectral data of synthesized compounds confirmed the formation of the final products. The inhibitory effects of 3(a-j) on carbonic anhydrase activity were determined, and it was found that derivative 3c exhibited the most potent activity with IC500.84 ± 0.12 μM among all other derivatives and is also more active than standard acetazolamide (IC500.91 ± 0.12). The enzyme inhibitory kinetics results determined by Lineweaver-Burk plots revealed that compound 3c inhibits the enzyme by noncompetitive mode of inhibition with K i value 8.6 μM. The molecular docking investigations of the synthesized analogues 3(a-j) were evaluated which assured that synthesized compounds bind well inside the active binding site of the target enzyme. Cytotoxicity on human keratinocyte (HaCaT) and MCF-7 cell lines was performed, and it was found that most of the synthesized analogues were nontoxic on these cell lines and the toxic effects follow the dose-dependent manner. Based on our investigations, it was suggested that analogue 3c may serve as core structure to project carbonic anhydrase inhibitors with greater potency.
Copyright © 2020 Mujahid Abas et al.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures








Similar articles
-
Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.Bioorg Med Chem. 2017 Jun 15;25(12):3093-3097. doi: 10.1016/j.bmc.2017.03.063. Epub 2017 Mar 31. Bioorg Med Chem. 2017. PMID: 28400084
-
Carbonic anhydrase inhibitors: synthesis of Schiff bases of hydroxybenzaldehydes with aromatic sulfonamides and their reactions with arylsulfonyl isocyanates.J Enzyme Inhib. 2000;15(6):533-46. doi: 10.3109/14756360009040708. J Enzyme Inhib. 2000. PMID: 11140609
-
Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors.Eur J Med Chem. 2022 Jan 15;228:114004. doi: 10.1016/j.ejmech.2021.114004. Epub 2021 Nov 20. Eur J Med Chem. 2022. PMID: 34847409
-
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.Bioorg Med Chem. 2014 Nov 1;22(21):5883-90. doi: 10.1016/j.bmc.2014.09.021. Epub 2014 Sep 21. Bioorg Med Chem. 2014. PMID: 25267005
-
Synthesis of Benzimidazole-Sulfonyl Derivatives and Their Biological Activities.Biochem Res Int. 2022 Apr 5;2022:7255299. doi: 10.1155/2022/7255299. eCollection 2022. Biochem Res Int. 2022. PMID: 35425644 Free PMC article. Review.
Cited by
-
Synthesis, Computational Studies, Antioxidant and Anti-Inflammatory Bio-Evaluation of 2,5-Disubstituted-1,3,4-Oxadiazole Derivatives.Pharmaceuticals (Basel). 2023 Jul 24;16(7):1045. doi: 10.3390/ph16071045. Pharmaceuticals (Basel). 2023. PMID: 37513956 Free PMC article.
References
-
- Kannan K. K., Notstrand B., Fridborg K., Lovgren S., Ohlsson A., Petef M. Crystal structure of human erythrocyte carbonic anhydrase B. Three-dimensional structure at a nominal 2.2-A resolution. Proceedings of the National Academy of Sciences. 1975;72(1):51–55. doi: 10.1073/pnas.72.1.51. - DOI - PMC - PubMed
-
- Maresca A., Scozzafava A., Vullo D., Supuran C. T. Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis. Journal of Enzyme Inhibition and Medicinal Chemistry. 2013;28(2):384–387. doi: 10.3109/14756366.2011.645539. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources